- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01519830
Iron Substitution in Blood Donors (ISUB)
Significance of Iron Deficiency in Transfusion Medicine: Effects of Iron Substitution on Fatigue Und General Well Being in Healthy Blood Donors
Depletion of iron stores is frequently observed in regular blood donors, but effects of iron deficiency on general health is not well studied. Recent studies in women suffering of fatigue suggest iron deficiency without concomitant anemia as a common cause of these complaints. Provided the same is true in healthy subjects, substitution of intravenous iron might result in an improvement of general well being in iron depleted blood donors.
Healthy regular blood donors will be screened for low storage iron. Qualifying subjects will be invited to participate in a randomized, placebo-controlled trial with substitution of intravenous iron or placebo (saline solution). Differences in subjectively felt fatigue and other factors of general health and well being will be assessed. If an improvement of such factors can be shown after iron replacement, relevant concerns about artificially lowering iron stores by repeated phlebotomies will arise and changes of monitoring and substitution policies in blood banking might have to be discussed.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background
Chronic iron deficiency causes anemia with impairment of physical and mental capacity. Since iron plays an essential role in many enzymes apart from oxygen carriage, iron deficiency was proposed as an independent factor impairing wellbeing also without anemia. Symptoms like fatigue, asthenia, physical weakness, mental impairment and many others have been associated with iron deficiency. Recent clinical trials with iron substitution in iron deficient women suffering of general fatigue support this hypothesis, but data are still conflicting and debated.
Low body iron stores are frequently observed in blood donors. Repeated phlebotomies may induce or aggravate severe iron deficiency. Astonishingly, little is known about the long term effects of reduced iron stores on general health of regular blood donors. Serious health impairment cannot be excluded conclusively. Since many symptoms associated with iron deficiency are subtle, they might be missed by otherwise healthy subjects.
Blood donors with borderline or decreased iron stores (i.e. serum ferritin below 50 microg/l) will be invited to participate in a randomized, placebo-controlled intervention study comparing intravenous iron carboxymaltose and a physiological saline solution (placebo). Subjectively felt fatigue, measured on a numeric rating scale from 1 to 10 as the major end point will be assessed before and six months after application of the study drug. As additional factors, various aspects of general wellbeing will be assessed using four psychometric questionnaires. Statistical analysis will compare the results before and after application of the study drug and the results of the two study arms.
Objective
- Assessment of severity of iron deficiency in a large group of blood donors.
- Demonstration of an improvement of fatigue after substitution of iron compared with placebo in iron deficient blood donors
- Detection of improved general wellbeing in otherwise healthy blood donors after substitution of intravenous iron
- Assessment of tolerability of intravenous iron in healthy blood donors
Methods
Randomized, placebo controlled interventional trial comparing the effect of intravenous iron or placebo on fatigue and various other factors of general wellbeing. Endpoints assessed on a numeric rating scale from 1 to 10 and four psychometric questionnaires.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Bern, Switzerland, CH-3010
- Department of Hematology, Bern University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Serum-Ferritin 50 microg/l
- Eligibility for blood donation
- At least one prior blood donation
Exclusion Criteria
- Anemia
- Known intolerability of intravenous iron
- History of anaphylactic reactions
- Active systemic infections
- Signs of chronic bleeding
- Known iron overload
- Lactation
- Pregnancy
- Any disease associated with increased fatigue
- Medication associated with increased fatigue
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Verum
Iron Carboxymaltose (Ferinject)
|
Intravenous iron
|
Placebo Comparator: Placebo
0.9% NaCl solution
|
0.9% NaCl solution
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Difference of fatigue on a 10 point numeric scale after intravenous substitution of iron or placebo
Time Frame: 6 weeks
|
measured by questionnaire
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of fatigue after intravenous substitution of iron
Time Frame: 6 weeks
|
measured by questionnaire
|
6 weeks
|
Improvement of general wellbeing
Time Frame: 6 weeks
|
measured by questionnaire
|
6 weeks
|
Number of patients with adverse events of different grades
Time Frame: 6 weeks
|
6 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Peter Keller, MD, Department of Hematology, Bern University Hospital, Switzerland
- Study Chair: Bernhard Lämmle, MD, Prof., Department of Hematology, Bern University Hospital, Switzerland
- Study Chair: Stefano Fontana, MD, Blutspendedienst SRK Bern AG, Bern, Switzerland
- Study Chair: Peter Jüni, MD, Prof., Institut für Sozial- und Präventivmedizin, Universität Bern, Switzerland
- Study Chair: Roland von Känel, MD, Prof., Kompetenzbereich für Psychosomatische Medizin, University Hospital Bern
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 010/11
- Swissmedic 2011DR3145
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fatigue
-
Bakulev Scientific Center of Cardiovascular SurgeryFoundation for the Support of Physical Culture and Sports BECOME A CHAMPION; Autonomous Non-Profit organization of additional education sports school BECOME A CHAMPIONNot yet recruitingEfficacy, Self | Fatigue, Mental | Fatigue; Muscle, Heart | Fatigue; CombatRussian Federation
-
Universita di VeronaUniversity of Southern CaliforniaCompletedDiet, Healthy | Fasting | Fatigue, Mental | Fatigue; Muscle, HeartItaly
-
University of ZurichRecruitingVocal FatigueSwitzerland
-
KU LeuvenCompleted
-
Société des Produits Nestlé (SPN)Maastricht University Medical CenterCompleted
-
University of Applied Sciences for Health Professions...University of Wisconsin, MilwaukeeCompleted
-
Taoyuan General HospitalCompleted
-
Alaa Yousri Mahmoud AtiaUnknownMuscle FatigueEgypt
-
University Hospital, Clermont-FerrandLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques...CompletedNeuromuscular FatigueFrance
-
Central Hospital, Nancy, FranceUniversity of Lorraine; Institut National de Recherche et de Sécurité, Nancy...Unknown
Clinical Trials on Iron carboxymaltose (Ferinject)
-
Tel-Aviv Sourasky Medical CenterWithdrawn
-
Medical University of GrazCompleted
-
Helsinki University Central HospitalRecruiting
-
Bayside HealthNational Health and Medical Research Council, Australia; Monash UniversityRecruiting
-
American Regent, Inc.CompletedIron Deficiency AnemiaUnited States
-
Universität des SaarlandesCompletedAnemia, Iron-DeficiencyGermany
-
Vifor PharmaPierrel Research Europe GmbHCompletedAnaemiaAustralia, Germany, Sweden, Switzerland, Turkey
-
Georg-Christian FunkUnknownPulmonary Disease, Chronic ObstructiveAustria
-
Maastricht University Medical CenterVifor PharmaTerminatedPostoperative AnaemiaNetherlands